Brilliant Bio Pharma Private Limited — Vaccine Exporter Profile
Indian Pharmaceutical Exporter · #10 for Vaccine · $5.4M export value · DGFT Verified
Brilliant Bio Pharma Private Limited is the #10 Indian exporter of Vaccine with $5.4M in export value and 108 verified shipments. Brilliant Bio Pharma Private Limited holds a 0.8% market share in Vaccine exports across 12 countries.
Brilliant Bio Pharma Private Limited — Vaccine Export Profile: Buyers & Destinations
Where Does Brilliant Bio Pharma Private Limited Export Vaccine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NEPAL | $1.1M | 42 | 59.4% |
| INDONESIA | $200.0K | 4 | 11.1% |
| CAMBODIA | $138.7K | 18 | 7.7% |
| BANGLADESH | $94.9K | 6 | 5.3% |
| OMAN | $69.4K | 3 | 3.8% |
| TAJIKISTAN | $59.7K | 17 | 3.3% |
| BHUTAN | $59.4K | 4 | 3.3% |
| ANGOLA | $46.6K | 2 | 2.6% |
| MYANMAR | $39.2K | 3 | 2.2% |
| SRI LANKA | $18.3K | 1 | 1.0% |
Brilliant Bio Pharma Private Limited exports Vaccine to 12 countries. The largest destination is NEPAL accounting for 59.4% of Brilliant Bio Pharma Private Limited's Vaccine shipments, followed by INDONESIA (11.1%) and CAMBODIA (7.7%). These destinations reflect Brilliant Bio Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vaccine from Brilliant Bio Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER. | NEPAL | $232.6K | 6 |
| TO NMB BANK LIMITED | NEPAL | $200.0K | 4 |
| TO THE ORDER... | NEPAL | $197.8K | 6 |
| TO THE ORDER | NEPAL | $112.2K | 3 |
| PT.BIOTS PRIMA AGRISINDO | INDONESIA | $100.0K | 2 |
| PT.BIOTIS PRIMA AGRISINDO | INDONESIA | $100.0K | 2 |
| TO STANDARD CHARTERED BANK NEPAL LT | NEPAL | $68.9K | 2 |
| JUMA ALI SULAIMAN AND PARTNERS CO.L | OMAN | $63.3K | 2 |
| PARUNA PHARMACEUTICAL & MEDICAL SUP | BHUTAN | $59.4K | 4 |
| M SMEDIVET CO LIMITED | CAMBODIA | $51.7K | 2 |
Brilliant Bio Pharma Private Limited supplies Vaccine to 43 buyers globally. The largest buyer is TO THE ORDER. (NEPAL), followed by TO NMB BANK LIMITED (NEPAL) and TO THE ORDER... (NEPAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vaccine Export Value and How Much Does Brilliant Bio Pharma Private Limited Contribute?
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Brilliant Bio Pharma Private Limited contributes $5.4M to this total, accounting for 0.8% of India's Vaccine exports. Brilliant Bio Pharma Private Limited ships Vaccine to 12 countries through 43 buyers.
What Is the Average Shipment Value for Brilliant Bio Pharma Private Limited's Vaccine Exports?
Brilliant Bio Pharma Private Limited's average Vaccine shipment value is $50.0K per consignment, based on 108 shipments totaling $5.4M. The largest destination is NEPAL (59.4% of Brilliant Bio Pharma Private Limited's Vaccine exports).
How Does Brilliant Bio Pharma Private Limited Compare to Other Indian Vaccine Exporters?
Brilliant Bio Pharma Private Limited ranks #10 among 325 Indian Vaccine exporters with a 0.8% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Brilliant Bio Pharma Private Limited processed 108 shipments to 12 destination countries.
What Vaccine Formulations Does Brilliant Bio Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FUTVAC(FOOT & MOUTH DISEASE VACCINE-INAC | $221.3K | 5 |
| FUTVAC (FOOT & MOUTH DISEASE VACCINE-INA | $200.0K | 4 |
| FOOT AND MOUTH DISEASE VACCINE 100ML PACK QTY 20 000NOS 20 00 000ML 2000 00LTRS AS PER INV | $200.0K | 4 |
| FOOT AND MOUTH DISEASE VACCINE -100ML PACK -QTY:20,000NOS = 20,00,000ML=2000.00LTRS (AS PER INV) | $100.0K | 2 |
| FUTVAC FOOT MOUTH DISEASE VACCINE INACTIVATED B P STRAINS O A ASIA 1 100 ML 50DOSE PACK BATCH NO 22FV22009 MDT NOV 22 | $62.2K | 2 |
| FUTVAC (FOOT & MOUTH DISEASE VACCINE)30M | $50.0K | 1 |
| HS VACCINE-100ML / 50 DOSE PACK HEMORRHAGIC SEPICAEMIA VACCINE IP | $50.0K | 1 |
| FUTVAC VACCINE-100ML/50 DOSE PACK(FOOT AND MOUTH DISEASE VACCINE-INACTIVATED TRIVALENT STRAINS-O,A&ASIA-1)BATCH NO. 25FVLTR | $50.0K | 1 |
| FUTVAC (FOOT AND MOUTH DISEASE VACCINE-INACTIVATED B.P.) BATCH NO. 22FV23002 //22FV23003,MFG DT.OCT-23 / DEC-23, EXP DT | $50.0K | 1 |
| FOOT AND MOUTH DISEASE VACCINE -QTY:3,15,100 NOS =6,30,200 ML=630.200 LTRS (AS PER INV) | $50.0K | 1 |
Brilliant Bio Pharma Private Limited exports 83 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FUTVAC(FOOT & MOUTH DISEASE VACCINE-INAC with 5 shipments worth $221.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Brilliant Bio Pharma Private Limited Compare to Nearest Vaccine Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | PANACEA BIOTEC LIMITED | $11.7M | 234 | 58 | $50.0K |
| 9 | CHIRON BEHRING VACCINES PRIVATE LIMITED | $5.5M | 111 | 9 | $50.0K |
| 10 | BRILLIANT BIO PHARMA PRIVATE LIMITED ★ | $5.4M | 108 | 12 | $50.0K |
| 13 | HESTER BIOSCIENCES LIMITED | $5.3M | 681 | 25 | $7.8K |
| 12 | ZYDUS LIFESCIENCES LIMITED | $4.5M | 90 | 16 | $50.0K |
Brilliant Bio Pharma Private Limited ranks #10 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are PANACEA BIOTEC LIMITED and CHIRON BEHRING VACCINES PRIVATE LIMITED.
Which Indian Ports Ship Vaccine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Brilliant Bio Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 108 individual customs records matching Brilliant Bio Pharma Private Limited exporting Vaccine, covering 83 formulations to 12 countries via 43 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Export Data from Brilliant Bio Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Brilliant Bio Pharma Private Limited's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Brilliant Bio Pharma Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Vaccine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Brilliant Bio Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.